Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 88,424 RXRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 88,424 | n/a |
| Feb 10, 2026 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Disposition to Issuer | 29,865 | n/a |
| Jun 23, 2025 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 11,008 | n/a |
| Jun 13, 2025 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Grant/Award | 5,758 | n/a |
| Mar 19, 2025 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/Award | 36,549 | n/a |
| May 29, 2024 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Grant/Award | 5,357 | n/a |
| May 31, 2023 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Grant/Award | 5,357 | n/a |
| May 27, 2022 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Grant/Award | 2,679 | n/a |
| Dec 15, 2021 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Grant/Award | 10,714 | n/a |
| Apr 1, 2021 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 10,196 | n/a |